Difference between revisions of "Diphenhydramine (Benadryl)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 9: | Line 9: | ||
''No known antineoplastic properties. Used for prevention of reactions to blood products or biologics (e.g. monoclonal antibodies) as well as treatment of such reactions.'' | ''No known antineoplastic properties. Used for prevention of reactions to blood products or biologics (e.g. monoclonal antibodies) as well as treatment of such reactions.'' | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Antihistamines]] | [[Category:Antihistamines]] | ||
[[Category:Drugs FDA approved in 1946]] | [[Category:Drugs FDA approved in 1946]] | ||
Revision as of 22:37, 13 June 2018
General information
Class/mechanism: first-generation antihistamine.
Route: PO/IV
Extravasation: unknown
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.
Diseases for which it is used
No known antineoplastic properties. Used for prevention of reactions to blood products or biologics (e.g. monoclonal antibodies) as well as treatment of such reactions.